Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Homeopathic Regulation Critics Will Swing For Change Against Industry Stalwarts At FDA Hearing

This article was originally published in The Tan Sheet

Executive Summary

In addition to marketers and trade groups, Gary Yingling, a former FDA counsel involved in the agency’s decision to omit homeopathics from the OTC drug review, will make a presentation at a public hearing April 20-21. FDA’s current approach as “a rational framework,” CHPA says.

You may also be interested in...

Science-Based Evaluation Advocates Want Tighter Homeopathic Oversight

Public health concerns should prompt FDA to tighten its regulation of homeopathic drugs, a citizen petition filed by the nonprofit Center for Inquiry says.

GNC, Rite Aid expansion plans

GNC and Rite Aid announce Aug. 7 an agreement that will nearly double the number of GNC LiveWell locations within Rite Aid stores nationwide by 2014. Under the contract, the firms expect 1,125 GNC locations to be added to the 1,300 currently operating inside Rite Aid stores; the agreement also provides Rite Aid with an option to extend the contract through 2019 and open 250 more stores during that time period. Rite Aid plans to add "several hundred" GNC store-within-Rite Aid store locations during its fiscal year, ending March 1, 2008...

CBD Safety And Hemp Farming Have Equal Space In Rep. Harris’ Concerns

“We ought to deal with this. There are questions on long-term safety and questions on efficacy claims that are just not proven,” says the Maryland Republican. “The biggest threat hanging over, in my mind, the farmers who want to grow hemp, is what if the FDA comes out tomorrow and says, ‘You can't sell any product’? The market collapses,”he said at a CBD policy conference.


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts